entity

HDAC2/HDAC3

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about HDAC2/HDAC3: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

5Connections
1Hypotheses
1Analyses
2Outgoing
3Incoming
0Experiments
1Debates

Wiki Pages (9)

Knowledge base pages for this entity

Epigenetic Dysregulation in Neurodegeneration

mechanism · 4376 words

PDLIM7 Epigenetic Activation in Parkinson's Disease

mechanism · 2652 words

Histone Modifications

entity · 1662 words

Metabolic-Epigenetic Axis in Neurodegeneration Synthesis

mechanism · 1658 words

Section 200: Epigenetic and Chromatin Therapy in CBS/PSP

therapeutic · 1613 words

Outgoing (2)

TargetRelationTypeStr
metabolic_neuroscienceassociated_withdisease0.40
benchmark_ot_ad_answer_key:HDAC2/HDAC3data_indataset_row0.00

Incoming (3)

SourceRelationTypeStr
Cp/Cebpα/Mir34A Pathwaymediatespathway0.90
h-d7212534targetshypothesis0.50
benchmark_ot_ad_answer_key:HDAC2/HDAC3data_indataset_row0.00

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Epigenetic Priming Ketone Protocol 0.736 metabolic neuroscience What determines the optimal timing and d

Mentioning Analyses (1)

Scientific analyses that reference this entity

What determines the optimal timing and dosing of ketogenic interventions for neu

metabolic neuroscience | 2026-04-03 | 7 hypotheses Top: 0.736

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

While ketone metabolism was discussed as therapeutic, the debate revealed no cle

active · Rounds: 4 · Score: 0.50 · 2026-04-03